Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-2016 Apply Investor Resources Results for 2024-2025 Allotment of 2,179 equity shares under ESOS 2013-A Scheme and bet9¹ÙÍø ESAR Scheme 2021 of the Company 20th Mar 2025 USFDA approval received for NDA submitted for Nilotinib Capsules 21st Feb 2025 USFDA inspection at analytical testing facility of Sitec Labs Limited in Mahape, Navi Mumbai, India 21st Feb 2025 Update on investment in bet9¹ÙÍø Medpro South Africa Proprietary Limited 19th Feb 2025 Presentation at Kotak Conference 18th Feb 2025 Allotment of 901 equity shares under ESOS 2013-A Scheme and bet9¹ÙÍø ESAR Scheme 2021 of the Company 13th Feb 2025 Schedule of Analyst / Institutional Investor Meeting 10th Feb 2025 Update on USFDA Inspection at Company’s manufacturing facility in Virgonagar, Bengaluru, India 10th Feb 2025 Investment in bet9¹ÙÍø Medpro South Africa Proprietary Limited, wholly owned subsidiary 03rd Feb 2025 Earnings Call Transcript Q3 FY25 31st Jan 2025 + Ìý and by TradingView The displayed data is not in real time and may have streaming delays.
